Paul Belliveau

2.0k total citations
56 papers, 1.5k citations indexed

About

Paul Belliveau is a scholar working on Infectious Diseases, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Paul Belliveau has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 15 papers in Pharmacology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Paul Belliveau's work include Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Paul Belliveau is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Paul Belliveau collaborates with scholars based in United States, Canada and Romania. Paul Belliveau's co-authors include David P. Nicolau, Richard Quintiliani, Collin D. Freeman, C H Nightingale, Jack Ross, C H Nightingale, Colin Freeman, Linda M. Spooner, Kwan Kew Lai and Sally A. Fontecchio and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Paul Belliveau

54 papers receiving 1.5k citations

Peers

Paul Belliveau

PHARM

EPIDE

SURGE

Ronald G. Hall United States

William Salzer United States

Jason C Gallagher United States

Milo Gatti Italy

Kevin J. Downes United States

Joan Korth‐Bradley United States

Lavern M. Vercaigne Canada

Dolors Soy Spain

Paul M. Beringer United States

P Periti Italy

Ronald G. Hall United States

Paul Belliveau

432 ×0.7

PHARM

313 ×0.7

EPIDE

637 ×1.7

199 ×0.8

98 ×0.4

SURGE

Citations per year, relative to Paul Belliveau Paul Belliveau (= 1×) peers Ronald G. Hall

Countries citing papers authored by Paul Belliveau

Since Specialization

Citations

This map shows the geographic impact of Paul Belliveau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Belliveau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Belliveau more than expected).

Fields of papers citing papers by Paul Belliveau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Belliveau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Belliveau. The network helps show where Paul Belliveau may publish in the future.

Co-authorship network of co-authors of Paul Belliveau

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Belliveau. A scholar is included among the top collaborators of Paul Belliveau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Belliveau. Paul Belliveau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cooper, M. R., et al.. (2023). Prioritizing Well-Being for a More Resilient Workforce. American Journal of Pharmaceutical Education. 87(8). 100470–100470. 1 indexed citations

Donovan, Jennifer L., et al.. (2017). Incorporating the American Pharmacists Association's Delivering Medication Therapy Management services certificate program into an accelerated pharmacy curriculum. Currents in Pharmacy Teaching and Learning. 9(5). 813–820. 3 indexed citations

Belliveau, Paul, et al.. (2016). Oritavancin: A Novel Lipoglycopeptide. The Consultant Pharmacist. 31(2). 86–95. 6 indexed citations

Aungst, Timothy Dy & Paul Belliveau. (2015). Leveraging mobile smart devices to improve interprofessional communications in inpatient practice setting: A literature review. Journal of Interprofessional Care. 29(6). 570–578. 12 indexed citations

Morin, Anna K., et al.. (2014). A Novel Structured Format for Engaging Pharmacy Students in Bioethics Discussions. American Journal of Pharmaceutical Education. 78(9). 171–171. 12 indexed citations

Belliveau, Paul, et al.. (2012). Inhaled Aztreonam Lysine for Cystic Fibrosis Pulmonary Disease–Related Outcomes. Annals of Pharmacotherapy. 46(7-8). 1076–1085. 6 indexed citations

Spooner, Linda M., et al.. (2011). Vigabatrin for Infantile Spasms. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(3). 298–311. 23 indexed citations

Belliveau, Paul, et al.. (2010). An Electronic NAPLEX Review Program for Longitudinal Assessment of Pharmacy Students' Knowledge. American Journal of Pharmaceutical Education. 74(7). 128–128. 9 indexed citations

Spooner, Linda M., et al.. (2009). Excretion of Antimicrobials Used to Treat Methicillin‐Resistant Staphylococcus aureus Infections During Lactation: Safety in Breastfeeding Infants. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(9). 1103–1109. 14 indexed citations

10.

Belliveau, Paul, et al.. (2008). Product and t echnology Mapping t ools for Planning and Portfolio decision Making. 5 indexed citations

11.

Silva, Matthew J., Michele L. Matthews, Courtney I. Jarvis, et al.. (2007). Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clinical Therapeutics. 29(2). 253–260. 154 indexed citations

12.

Belliveau, Paul, et al.. (2005). Evaluation of Omalizumab From a Health Plan Perspective. Journal of Managed Care Pharmacy. 11(9). 735–745. 20 indexed citations

13.

Belliveau, Paul, et al.. (2001). PDMA toolbook of new product development. Data Archiving and Networked Services (DANS). 16 indexed citations

14.

Lai, Kwan Kew, et al.. (1998). Failure to Eradicate Vancomycin-Resistant Enterococci in a University Hospital and the Cost of Barrier Precautions. Infection Control and Hospital Epidemiology. 19(9). 647–652. 80 indexed citations

15.

Klepser, Michael E., Zhu Zhu, David P. Nicolau, et al.. (1996). Oral Absorption of Trimethoprim‐Sulfamethoxazole in Patients with AIDS. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(4). 656–662. 13 indexed citations

16.

Lai, Kwan Kew, J. E. Kleinjan, & Paul Belliveau. (1996). Vancomycin-Induced Neutropenia Treated with Granulocyte Colony-Stimulating Factor During Home Intravenous Infusion Therapy. Clinical Infectious Diseases. 23(4). 844–845. 20 indexed citations

17.

Belliveau, Paul, et al.. (1996). Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium. American Journal of Health-System Pharmacy. 53(13). 1570–1575. 25 indexed citations

18.

Belliveau, Paul, Collin D. Freeman, David P. Nicolau, et al.. (1996). Serum bactericidal activity of ceftizoxime and ceftriaxone against pathogens associated with community-acquired and nosocomial pneumonias. American Journal of Health-System Pharmacy. 53(9). 1024–1027. 6 indexed citations

19.

Belliveau, Paul, et al.. (1993). Institution‐Specific Patterns of Infection and Gram's Stain as Guides for Empiric Treatment of Patients Hospitalized With Typical Community‐Acquired Pneumonia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(4). 396–401. 4 indexed citations

20.

Freeman, Collin D., David P. Nicolau, Paul Belliveau, & C H Nightingale. (1993). Lomefloxacin Clinical Pharmacokinetics. Clinical Pharmacokinetics. 25(1). 6–19. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact